Can virtual reality bring stroke rehab home?

NCT ID NCT04307108

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 18, 2026 · Last updated Aug 19, 2026 · Updated 1 time

Summary

This study tests whether a virtual reality (VR) system called MAGIC-GLASS is usable and acceptable for stroke survivors to use at home as part of their rehabilitation. Participants wear a headset that shows virtual hands responding to their own movements, and they play mini-games designed to aid recovery. The system also lets clinicians monitor progress remotely. Researchers will measure changes in movement, how much participants use the system, and gather feedback from users, carers, and clinicians to see if this approach could fit into standard stroke care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
MAGIC-GLASS, a virtual reality (VR) home rehabilitation system with mini-games and remote clinician support
What this could lead to
If it works, this VR system could offer stroke survivors a way to do more rehabilitation exercises at home, with remote support, potentially improving recovery and independence.
What could go wrong
This is an early-stage study focused on usability and acceptability, not on proving effectiveness. The system may not be practical for all users, and results may not generalize beyond this group.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

111 people

The number who actually took part.

Started

Nov 2018

Finished

Jun 2020

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Any time point post stroke * Medically stable (and without uncontrolled seizures or vertigo) * No or mild cognitive deficit: can follow two step commands * No significant visual or spatial neglect (Can turn head towards an image when asked to do so and keep attention). People with hemianopia or other visual deficits can be included dependent on clinical opinion * Normal or normal corrected vision * Be able to get in and out from a seat with assistance; can be used in a wheelchair as long as arms can rest on table * Have a carer to assist putting on the headset * Be willing to give consent * For those not using mirror therapy, can move impaired arm without significant pain Exclusion Criteria: * • People with a moderate to severe cognitive impairment (MoCA\<20). * Those with a visual impairment who are unable to see a clear image with the headset. * Patients with severe neuropsychological deficits such as severe neglect or apraxia as indicated by their clinical team. * Patients who are medically unwell e.g. with history of solid organ or bone marrow transplantation, active malignancy within 24 months prior to screening or metastatic cancer, life expectancy less than 6 months, Congestive heart failure in New York Heart Association (NYHA) Functional Classification IV (severe) stage. * Those with complete dependency in Activities of Daily Living, any medical or other reason (e.g. known or suspected inability of the participant to comply with the protocol procedure) that investigator opinion that the participant is unsuitable for the study. * Patients unwilling to provide consent and those who cannot be followed-up at any time point will be excluded from the study. * Epilepsy, seizures and history of vertigo (possible exclusion determined by clinician). * Those with upper limb sensory disturbance who are unwilling to keep their nails short for the duration of the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Neuro-rehabilitation Department of the University Hospital of Ancona.

    Ancona, Italy

  • Southern Health and Social Care Trust

    Lurgan, United Kingdom

  • Western Health and Social Care Trust

    Londonderry, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.